30-d Rand, Eval-blind, Controlled, Multi-centre, Parallel, ph III Study to Evaluate Effect of a Low Maint Dose Ticagrelor Regimen vs Standard Dose Clopidogrel on Coronary Flow Reserve in DM Patients With Impaired Microvascular Function Without Prior MI or Stroke Undergoing ePCI
Latest Information Update: 04 Nov 2021
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Coronary artery disease
- Focus Pharmacodynamics
- Acronyms AUGEAS
Most Recent Events
- 06 Apr 2020 Status changed from discontinued to withdrawn prior to enrolment.
- 27 Jan 2020 Status changed from recruiting to discontinued.
- 17 Sep 2019 Status changed from not yet recruiting to recruiting.